Open AccessUsing Low-Dose Methylprednisolone in Early ARDS Leads to a More Rapid Improvement in Lung Function
Author(s) -
Richard Appleton
Publication year - 2009
Publication title -
journal of the intensive care society
Language(s) - English
Resource type - Journals
eISSN - 2057-360X
pISSN - 1751-1437
DOI - 10.1177/175114370901000313
Subject(s) - ards , methylprednisolone , medicine , mechanical ventilation , acute respiratory distress , lung function , anesthesia , randomized controlled trial , lung , respiratory distress , intensive care medicine
Treating ventilated patients within 72 hours of the diagnosis of acute respiratory distress syndrome (ARDS) with prolonged low dose methylprednisolone leads to a more rapid improvement in lung function and may reduce the duration of mechanical ventilation and ICU stay. Level of evidence: 1 − (RCT with a high risk of bias)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom